ELENA TIMCHENKO: Open Payments
NPI 1487305272 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 9 payments from 7 companies in 2025. Trend: 2023 $22 · 2024 $134 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $87 |
| AstraZeneca Pharmaceuticals LP | 1 | $74 |
| Janssen Biotech, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $28 |
| Exelixis Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Nubeqa, ERLEADA, PLUVICTO, Trodelvy, CABOMETYX, KEYTRUDA.
Industry payments across PA — which companies pay providers there.
